News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

April 29, 2022
April 29, 2022
Categories

Interview with Dr. Robert Ferris: Head and neck cancer treatment evolution leads the way for future developments

Do you like it?
Read more
April 11, 2022
April 11, 2022
Categories

As NCI-MATCH winds down, cancer research community takes stock of lessons learned

Do you like it?
Read more
April 9, 2022
April 9, 2022
Categories

Study finds potential association between allostatic load and worse overall survival in multiple myeloma

Do you like it?
Read more
April 9, 2022
April 9, 2022
Categories

Mixed quality of life findings following treatment highlight need for breast cancer support services

Do you like it?
Read more
April 7, 2022
April 7, 2022
Categories

African ancestry, high BMI predictive of worse breast cancer outcomes

Do you like it?
Read more
March 25, 2022
March 25, 2022
Categories

Enrollment in TMIST breast cancer screening trial surpasses halfway mark; Black participation rises above 20%

Do you like it?
Read more
March 25, 2022
March 25, 2022
Categories

Press Release: Enrollment in TMIST breast cancer screening trial surpasses halfway mark; recruitment of women from diverse backgrounds is key to success

Do you like it?
Read more
March 17, 2022
March 17, 2022
Categories

NCI-MATCH umbrella trial adds arm for LAG-3 expressing, mismatch repair deficient cancers

Do you like it?
Read more
March 16, 2022
March 16, 2022
Categories

Press Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations

Do you like it?
Read more
March 15, 2022
March 15, 2022
Categories

The results of the EA8141 phase II trial are part of mounting evidence showing the benefits of neoadjuvant chemotherapy

Do you like it?
Read more
March 10, 2022
March 10, 2022
Categories

Travel Funds Available for CRAs to Attend the Spring 2022 Group Meeting

Do you like it?
Read more
March 8, 2022
March 8, 2022
Categories

JAMA Oncology publishes TAILORx data showing racial and neighborhood disparities in breast cancer

Do you like it?
Read more
March 1, 2022
March 1, 2022
Categories

FDA notes the NCI-MATCH trial in its release of new guidance on master protocols and expansion cohorts

Do you like it?
Read more
February 28, 2022
February 28, 2022
Categories

Dr. Edith Mitchell discusses ECOG-ACRIN’s work to improve representation of minority populations in cancer clinical trials

Do you like it?
Read more
February 28, 2022
February 28, 2022
Categories

E1912 and other trials spur emergence of small molecule-inhibitor therapies for chronic lymphocytic leukemia

Do you like it?
Read more
December 21, 2021
December 21, 2021
Categories

Press Release: A new post-surgery approach for treating HPV-related throat cancer uses less radiation safely and spares the majority of patients from chemotherapy

Do you like it?
Read more
November 26, 2021
November 26, 2021
Categories

Treatment sequence impacts survival in BRAF-mutant metastatic melanoma

Do you like it?
Read more
November 16, 2021
November 16, 2021
Categories

Press Release: Practice-changing trial results for advanced skin cancer

Do you like it?
Read more
November 15, 2021
November 15, 2021
Categories

Press Release: Mitchell D. Schnall re-elected as Group Co-Chair of the ECOG-ACRIN Cancer Research Group

Do you like it?
Read more
November 12, 2021
November 12, 2021
Categories

NCTN group chairs, experts: Diverse representation of minorities in clinical trials and drug development saves lives

Do you like it?
Read more
Load more
News and Info

News

News and Info
Media Contact:
Diane Dragaud, MA
Director of Communications

Send an email

215-789-3631

Categories


Tags

Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Advocacy Bladder cancer Blood cancer Brain Cancer Breast cancer Cancer screening Cancer treatment Chemotherapy Clinical trial ComboMATCH Disparities Diversity Gastric cancer Gene testing Genomic testing GI cancer Group meeting Head and neck cancer Health equity Immunotherapy In memory Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Multiple myeloma myeloMATCH NCI-MATCH Pancreatic cancer Personalized screening Personalized treatment Precision medicine Precision oncology Prostate cancer Radiology Research results Sarcoma Social determinants of health (SDoH) Survivorship TMIST Treatment trial

 
ECOG-ACRIN Cancer Research Group